GKB Ophthalmics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2025 ,inter alia, to consider and approve the Unaudited Standalone and ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
GKB Ophthalmics has informed BSE that its Board of Directors will meet on August 14, 2025, at the registered office in Goa, to consider and approve the Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2025 (Q1 FY26). This is a routine regulatory intimation filed under SEBI's Listing Regulations. The trading window for designated persons has been closed since July 1, 2025, and will reopen 48 hours after the results are submitted to the stock exchange. No financial figures or business details are disclosed in this notice.
This is a standard procedural filing with no direct impact on the stock. Investors should await the actual Q1 FY26 results on August 14 to assess the company's financial performance.